NCT03298828 CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma Status UNKNOWN Phase PHASE1
NCT03286634 ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03286114 Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab Status TERMINATED Phase PHASE1
NCT03275493 CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT03272633 Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies Status TERMINATED Phase EARLY_PHASE1
NCT03267186 Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT03267030 Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase Status COMPLETED Phase PHASE2
NCT03263572 Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT03249636 New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia Status UNKNOWN Phase N/A
NCT03246906 Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation Status TERMINATED Phase PHASE2
NCT03226704 Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing Status ENROLLING_BY_INVITATION Phase N/A
NCT03204916 Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT03195010 Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia Status TERMINATED Phase PHASE2
NCT03187977 Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI Status COMPLETED Phase NA
NCT03187691 Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia Status WITHDRAWN Phase PHASE2
NCT03178617 High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT03147612 Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03147365 Effect of Different Exercises on Quality of Life of Leukemia Patients. Status COMPLETED Phase NA